April 17, 2018 by Chain Drug Review
Claire McCaskill, Debbie Stabenow, pharmacy gag clauses, Sen. Susan Collins
Issue 04-09-2018, News
WASHINGTON — Three senators last month introduced legislation that they say will bring more transparency to prescription drug pricing. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
March 16, 2018 by Chain Drug Review
American Pharmacists Association, B. Douglas Hoey, Claire McCaskill, CVS Health, Debbie Stabenow, Know the Lowest Price Act, National Community Pharmacists Association, Patient Right to Know Drug Prices Act, Pharmaceutical Care Management Association, pharmacy gag clauses, prescription drug pricing transparency, S. 2553, S. 2554, Susan Collins, Tom Menighan
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — A group of senators are sponsoring legislation to bring more prescription drug pricing transparency to the pharmacy counter. Sens. Susan Collins (R., Maine), Claire McCaskill (D., Mo.) and Debbie Stabenow (D., Mich.) yesterday introduced the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), which would
August 24, 2016 by Chain Drug Review
Amy Klobuchar, anaphylaxis, Chuck Grassley, Claire McCaskill, epinephrine auto-injector, EpiPen, mylan, Richard Blumenthal, Susan Collins
Pharmacy, Supplier News, Uncategorized
NEW YORK — Senate leaders have voiced concerns about a price surge for Mylan Inc.’s EpiPen, an epinephrine auto-injector for treating anaphylaxis, or potentially life-threatening allergic reactions. Sen. Chuck Grassley (R, Iowa), chairman of the Senate Judiciary Committee, and Sens. Susan Collins (R., Maine) and Claire McCaskill (D., Mo.), chairman and ranking member of the
November 4, 2015 by Chain Drug Review
Claire McCaskill, drug prices, pharmaceutical industry, pharmaceutical pricing, Senate Special Committee on Aging, Susan Collins
Business, Leading Headlines, Pharmacy, Retail News
WASHINGTON — A U.S. Senate committee has begun a probe of recent spikes in pharmaceutical pricing. Sens. Susan Collins (R., Maine) and Claire McCaskill (D., Mo.), who lead the Senate Special Committee on Aging, on Wednesday said the bipartisan investigation will include hearings, with the first slated for next month. The lawmakers noted that the